BioCentury
ARTICLE | Management Tracks

Francisco Ballester to retire from Sandoz

Plus: Boundless Bio hires a new CMO and updates from Avanzanite and George Medicines

February 4, 2025 12:45 AM UTC

Francisco Ballester will retire from Sandoz Group AG (SIX:SDZ; Pink:SDZNY) as president, region international, on March 1, when he will be succeeded by Peter Stenico after 34 years with the company. Stenico is global platform head, biosimilars and country president Sandoz Austria.

Boundless Bio Inc. (NASDAQ:BOLD) hired Robert Doebele as CMO. Doebele succeeds interim CMO James Freddo, who took over following the departure of CMO Klaus Wagner at the end of December. Boundless is leveraging extrachromosomal DNA to develop treatments for patients with cancers having amplified oncogenes. ...